^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ColoSeq™

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
News
ColoSeq™ is a comprehensive genetic test for hereditary colon cancer that uses next-generation sequencing to detect most mutations in AKT1, APC, AXIN2, BMPR1A, CDH1, CHEK2, CTNNA1, EPCAM, GALNT12, GREM1, MLH1, MSH2, MSH3, MSH6, MUTYH, NTHL1, PDGFRA, PIK3CA, PMS2, POLD1, POLE, PTEN, RPS20, SMAD4, STK11, and TP53. The assay completely sequences all exons, introns, and flanking regions of these genes AND detects large deletions and duplications.
Cancer:
Colon Cancer, Endometrial Cancer
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), APC (APC Regulator Of WNT Signaling Pathway), CDH1 (Cadherin 1), CHEK2 (Checkpoint kinase 2), CTNNA1 (Catenin Alpha 1), EPCAM (Epithelial cell adhesion molecule)
See More ...
Method:
Next-Generation Sequencing (NGS)